Literature DB >> 24384999

Painful bladder syndrome: an update and review of current management strategies.

Anthony J Dyer1, Christian O Twiss.   

Abstract

Interstitial cystitis/painful bladder syndrome (IC/PBS) remains a prevalent, but untreated disease with a poorly understood pathophysiology. Nonetheless, four main processes currently appear to be involved in producing IC/PBS symptoms: (1) disruption of the bladder GAG/proteoglycan layer, (2) upregulated immune/inflammatory response, (3) neural upregulation, and (4) pelvic floor dysfunction. Current and emerging therapies aimed at these potential targets will be the focus of this review with an update on IC/PBS therapy.

Entities:  

Mesh：

Year:  2014        PMID： 24384999     DOI： 10.1007/s11934-013-0384-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  124 in total

Review 1.  Interstitial cystitis and systemic autoimmune diseases.

Authors:  Joop P van de Merwe
Journal:  Nat Clin Pract Urol       Date:  2007-09

2.  Risk factors that affect the treatment of interstitial cystitis using intravesical therapy with a dimethyl sulfoxide cocktail.

Authors:  Man-Jung Hung; Yi-Ting Chen; Pao-Sheng Shen; Shih-Tien Hsu; Gin-Den Chen; Esther Shih-Chu Ho
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

Review 3.  Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review.

Authors:  Sahithi Tirumuru; Deyaa Al-Kurdi; Pallavi Latthe
Journal:  Int Urogynecol J       Date:  2010-05-07       Impact factor: 2.894

4.  Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.

Authors:  Harris E Foster; Philip M Hanno; J Curtis Nickel; Christopher K Payne; Robert D Mayer; David A Burks; Claire C Yang; Toby C Chai; Karl J Kreder; Kenneth M Peters; Emily S Lukacz; Mary P FitzGerald; Liyi Cen; J Richard Landis; Kathleen J Propert; Wei Yang; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2010-03-29       Impact factor: 7.450

5.  Limbic associated pelvic pain: a hypothesis to explain the diagnostic relationships and features of patients with chronic pelvic pain.

Authors:  Bradford W Fenton
Journal:  Med Hypotheses       Date:  2007-02-09       Impact factor: 1.538

6.  Primary treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen: 10-year experience.

Authors:  J P Weiss; D M Mattei; E C Neville; P M Hanno
Journal:  J Urol       Date:  1994-06       Impact factor: 7.450

7.  The use of amitriptyline in patients with urinary frequency and pain.

Authors:  K Pranikoff; G Constantino
Journal:  Urology       Date:  1998-05       Impact factor: 2.649

8.  Fulguration for Hunner ulcers: long-term clinical outcomes.

Authors:  Joel H Hillelsohn; Soroush Rais-Bahrami; Justin I Friedlander; Zhamshid Okhunov; Mahyar Kashan; Lisa Rosen; Robert M Moldwin
Journal:  J Urol       Date:  2012-10-22       Impact factor: 7.450

9.  Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis.

Authors:  B A O'Reilly; P L Dwyer; G Hawthorne; S Cleaver; E Thomas; A Rosamilia; M Fynes
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

10.  DIMETHYL SULFOXIDE (DMSO): A NEW CONCEPT IN PHARMACOTHERAPY.

Authors:  S W JACOB; M BISCHEL; R J HERSCHLER
Journal:  Curr Ther Res Clin Exp       Date:  1964-02
View more
  8 in total

1.  Important role of physicians in addressing psychological aspects of interstitial cystitis/bladder pain syndrome (IC/BPS): a qualitative analysis.

Authors:  Gregory Kanter; Katherine A Volpe; Gena C Dunivan; Sara B Cichowski; Peter C Jeppson; Rebecca G Rogers; Yuko M Komesu
Journal:  Int Urogynecol J       Date:  2016-08-31       Impact factor: 2.894

Review 2.  [Chronic pelvic pain].

Authors:  O Moormann; I Gralow
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

3.  Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.

Authors:  Rheal A Towner; Nataliya Smith; Debra Saunders; Samuel B Van Gordon; Amy B Wisniewski; Karl R Tyler; Beverley Greenwood-Van Meerveld; Robert E Hurst
Journal:  J Urol       Date:  2014-11-14       Impact factor: 7.450

4.  Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial.

Authors:  Gregory Kanter; Yuko M Komesu; Fares Qaedan; Peter C Jeppson; Gena C Dunivan; Sara B Cichowski; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2016-04-26       Impact factor: 2.894

5.  Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study.

Authors:  Hao Wang; Lucille J Russell; Kathleen M Kelly; Steven Wang; John Thipphawong
Journal:  BMC Urol       Date:  2017-01-05       Impact factor: 2.264

6.  Relationship of Bladder Pain With Clinical and Urinary Markers of Neuroinflammation in Women With Urinary Urgency Without Urinary Incontinence.

Authors:  Alex Soriano; Uduak Andy; Daisy Hassani; Kristene Whitmore; Heidi Harvie; Anna P Malykhina; Lily Arya
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-02-01       Impact factor: 1.913

Review 7.  Recommendations to the primary care practitioners and the patients for managing pelvic pain, especially in painful bladder syndrome for early and better prognosis.

Authors:  Kyung Jin Chung; Adelaide Na Yeon Han; Khae Hawn Kim
Journal:  J Exerc Rehabil       Date:  2015-10-30

Review 8.  The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome.

Authors:  Ran Pang; Abdullah Ali
Journal:  Transl Androl Urol       Date:  2015-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.